Micron scores a double upgrade, but trader sees better opportunity in another chipmaker stock
Micron scores a double upgrade, but trader sees better opportunity in another chipmaker stock"
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
In this article * CFG Follow your favorite stocksCREATE FREE ACCOUNT Micron Technology just soared to highs not seen in more than 20 years. After scoring a double upgrade from Citi, the
stock on Tuesday hit its highest peak since September 2000. Citi analysts also gave a $100 price target on an expected upturn in memory chip demand. The stock closed Tuesday's trading
at $77.26. Not everyone is as bullish on the stock. While Strategic Wealth Partners President Mark Tepper sees Micron as a hold, he worries that any supply and demand issues could put a dent
in momentum. "It's a very, very cyclical semi, and their product really in my opinion is the input to technology, it's not technology itself, so I'd rather own the
technology," Tepper told CNBC's "Trading Nation" on Tuesday. "Nvidia is the way to go. That's our largest chip exposure, and they're in all the
fastest-growing end markets that we find exciting — AI, autonomous vehicles, cloud, gaming. So I think they've got the best chips. Nvidia, they're innovating, so that's where
I'd be." Micron specializes in memory and storage chips; Nvidia, also a semiconductor company, is known for its graphics processing chips. In the same CNBC interview, MKM Partners
chief market technician JC O'Hara said Micron's technical setup supports Citi's bullish case. "This chart looks fantastic," he said. "There was a massive
breakout last November. That breakout came from a three-year base where Micron traded in a $30 range. Now, typically what follows these breakouts after a long period of consolidation is a
very powerful bull run, which I believe we are still on right now." O'Hara said the next move could take Micron to $85 in the near term — 10% upside from its Tuesday close.
Upcoming earnings could pose a risk or present a catalyst for the stock, he added. The company is set to report Thursday. _Disclosure: Strategic Wealth Partners holds NVDA._ _Disclaimer_
Trending News
New benefits could be covered under medicare advantageMemorial Day Sale! Join AARP for just $11 per year with a 5-year membership Join now and get a FREE gift. Expires 6/4 G...
🌟 bringing sports to life for the visually impaired! 🏟️👓THE TECHNOLOGY IS NOT YET WIDELY AVAILABLE BUT REMAINS FREE TO USE AT CERTAIN VENUES THANKS TO PARTNERSHIPS A headset th...
Prenatal Diagnosis in Germany | European Journal of Human GeneticsABSTRACT Prenatal diagnosis (PND) in Germany is well established. A wide spectrum of sonographic, cytogenetic, molecular...
Oops! That page can't be foundOops! That page can't be found It seems we can't find what you're looking for.Latest from HITC More latest from HITC...
Identification and characterization of a human mitochondrial nad kinaseABSTRACT NAD kinase is the sole NADP+ biosynthetic enzyme. Despite the great significance of NADP+, to date no mitochond...
Latests News
Micron scores a double upgrade, but trader sees better opportunity in another chipmaker stockIn this article * CFG Follow your favorite stocksCREATE FREE ACCOUNT Micron Technology just soared to highs not seen in ...
New benefits could be covered under medicare advantageMemorial Day Sale! Join AARP for just $11 per year with a 5-year membership Join now and get a FREE gift. Expires 6/4 G...
The good doctor: what condition does dr shaun murphy have?The actor also spoke to USA Today about wanting to portray the character and his condition in a fully-formed way. He sai...
'work of art' war film with almost perfect rating shows real horrors of combatThe director of this war film aimed to depict the lives of those who fought, rather than simply retelling the events, an...
Modules for molecules | NatureAccess through your institution Buy or subscribe This is a preview of subscription content, access via your institution ...